by FiveSenses | Sep 25, 2023 | News Release
Vancouver, BC, Canada, September 25th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that its... 
by FiveSenses | Sep 25, 2023 | Communiqué de presse
Vancouver, C.-B., Canada, 25 septembre 2023 – Defence Therapeutics Inc. (« Defence » ou la « Société »), une entreprise biopharmaceutique canadienne spécialisée dans le développement de vaccins et de technologies d’administration de médicaments immuno-oncologiques, a... 
by FiveSenses | Sep 25, 2023 | Communiqué de presse
Vancouver, C.-B., Canada, 22 septembre 2023 – Defence Therapeutics Inc. (« Defence » ou la « Société »), une entreprise biopharmaceutique canadienne spécialisée dans le développement de vaccins et de technologies d’administration de médicaments immuno-oncologiques, a... 
by FiveSenses | Sep 25, 2023 | News Release
Vancouver, BC, Canada, September 22nd, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce it has... by FiveSenses | Sep 12, 2023 | News Release
Vancouver, BC, Canada, September 12th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), one of the leading Canadian biotechnology companies, is pleased to announce its continuation to bringing innovative strategies aimed at targeting various...
Recent Comments